M. Aguilar

发表

Using artificial neural networks in clinical neuropsychology: High performance in mild cognitive impairment and Alzheimer's disease

Alfredo Robles, José Luis Molinuevo, Gonzalo Sánchez-Benavides, 2012, Journal of clinical and experimental neuropsychology.

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer ' s disease

D. G. Clark, M. Fornage, A. Hofman, 2022 .

123I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component

M. Aguilar, J. Krupiński, M. Slevin, 2015, Front. Syst. Neurosci..

Diagnostic Validity of the Alzheimer's Disease Functional Assessment and Change Scale in Mild Cognitive Impairment and Mild to Moderate Alzheimer's Disease

J. Molinuevo, G. Sánchez-Benavides, M. Aguilar, 2014, Dementia and Geriatric Cognitive Disorders.

Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases

A. Lleó, P. Pástor, I. Zerr, 2020, Cells.

[Normalization of cognitive and functional assessment instruments for dementia (NORMACODEM) (I): objectives, content and population].

M. Aguilar, R. Blesa, J. Peña-Casanova, 1997, Neurologia.

[Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project].

M. Aguilar, R. Blesa, J. Peña-Casanova, 2007, Neurologia.

Spanish multicenter normative studies (Neuronorma project): norms for the abbreviated Barcelona Test.

Alfredo Robles, José Luis Molinuevo, Gonzalo Sánchez-Benavides, 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

One-Year Reference Norms of Cognitive Change in Spanish Old Adults: Data from the NEURONORMA Sample.

G. Sánchez-Benavides, M. Aguilar, A. Robles, 2016, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).

J. Molinuevo, B. Gómez-Anson, G. Sánchez-Benavides, 2014, Journal of Alzheimer's disease : JAD.

Clinical validity of the ‘mini-mental state’ for Spanish speaking communities

M. Aguilar, R. Blesa, J. Peña-Casanova, 2001, Neuropsychologia.

Clinical Validity and Utility of the Interview for Deterioration of Daily Living in Dementia for Spanish-Speaking Communities

J Peña-Casanova, M. Aguilar, R. Blesa, 1998, International Psychogeriatrics.

The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease

P. Delwaide, M. Merello, A. Castro-Caldas, 2006, Movement disorders : official journal of the Movement Disorder Society.

The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease

E. Tolosa, C. Broeckhoven, M. Aguilar, 1997, Neuroscience Letters.

Spanish multicenter normative studies (NEURONORMA project): normative data and equivalence of four BNT short-form versions.

J. Molinuevo, G. Sánchez-Benavides, M. Aguilar, 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].

M. Aguilar, R. Blesa, J. Peña-Casanova, 1997, Neurologia.

[Diagnostic value and test-retest reliability of the Blessed Dementia Rating Scale for Alzheimer's disease: data from the NORMACODEM project].

M. Aguilar, R. Blesa, J. Peña-Casanova, 2005, Neurologia.

PHARMACODYNAMICS OF THE ORAL BACE INHIBITOR JNJ-54861911 IN EARLY ALZHEIMER'S DISEASE

Vikash K. Sinha, S. Engelborghs, I. Tesseur, 2016, Alzheimer's & Dementia.